Jason Zemansky
Stock Analyst at B of A Securities
(4.81)
# 99
Out of 4,876 analysts
40
Total ratings
74.07%
Success rate
34.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $94 → $109 | $99.49 | +9.56% | 10 | Jun 11, 2025 | |
| KROS Keros Therapeutics | Downgrades: Neutral | $32 → $18 | $13.49 | +33.43% | 2 | Jun 10, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $32 → $9 | $2.53 | +255.73% | 1 | May 28, 2025 | |
| CYTK Cytokinetics | Maintains: Neutral | $62 → $54 | $33.16 | +62.85% | 4 | Apr 15, 2025 | |
| TVTX Travere Therapeutics | Maintains: Buy | $29 → $31 | $14.77 | +109.88% | 4 | Apr 1, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $22 → $17 | $7.95 | +113.84% | 5 | Feb 19, 2025 | |
| KURA Kura Oncology | Maintains: Buy | $36 → $29 | $5.67 | +411.46% | 2 | Nov 22, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $30 → $31 | $9.03 | +243.49% | 3 | Aug 15, 2024 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | $2.9 → $2.5 | $0.99 | +151.61% | 5 | Jun 20, 2024 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $9 → $10 | $1.02 | +880.39% | 4 | May 12, 2023 |
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $94 → $109
Current: $99.49
Upside: +9.56%
Keros Therapeutics
Jun 10, 2025
Downgrades: Neutral
Price Target: $32 → $18
Current: $13.49
Upside: +33.43%
Rocket Pharmaceuticals
May 28, 2025
Maintains: Buy
Price Target: $32 → $9
Current: $2.53
Upside: +255.73%
Cytokinetics
Apr 15, 2025
Maintains: Neutral
Price Target: $62 → $54
Current: $33.16
Upside: +62.85%
Travere Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $14.77
Upside: +109.88%
Arcus Biosciences
Feb 19, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $7.95
Upside: +113.84%
Kura Oncology
Nov 22, 2024
Maintains: Buy
Price Target: $36 → $29
Current: $5.67
Upside: +411.46%
Syndax Pharmaceuticals
Aug 15, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $9.03
Upside: +243.49%
Esperion Therapeutics
Jun 20, 2024
Downgrades: Underperform
Price Target: $2.9 → $2.5
Current: $0.99
Upside: +151.61%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.02
Upside: +880.39%